Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease

NCT06297681 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

M-protein Related Cardiac Disease

Interventions

DRUG: Daratumumab + Bortezomib + Dexamethasone + Dapagliflozin

Sponsor

Beijing Chao Yang Hospital

Collaborators

[object Object]
[object Object]